Integrin α2β1 in tumorigenic human osteosarcoma cell lines regulates cell adhesion, migration, and invasion by interaction with type I collagen

Cell Growth and Differentiation

Volumn 7, Issue 4, 1996, Pages 439-447

  Vihinen, Pia ^a   Riikonen, Terhi ^a   Laine, Aire ^b   Heino, Jyrki ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b ORION CORPORATION   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; INTEGRIN;

ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL INVASION; CELL MIGRATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; OSTEOSARCOMA; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD; CALCIUM; CELL ADHESION; CELL MOVEMENT; COLLAGEN; FIBRONECTINS; FLOW CYTOMETRY; HUMANS; INTEGRIN ALPHA2; INTEGRINS; LAMININ; MAGNESIUM; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; OSTEOCYTES; OSTEOSARCOMA; PRECIPITIN TESTS; RECEPTORS, COLLAGEN; TRANSFECTION; TUMOR CELLS, CULTURED;

KIRSTEN MURINE SARCOMA VIRUS;

EID: 0029852955     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Ruoslahti, E. Control of cell motility and tumor invasion by extracellular matrix interactions. Br. J. Cancer, 66: 239-242, 1992.
2. Hynes, R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69: 11-25, 1992.
3. Yokosaki, Y., Palmer, E. L., Prieto, A. L., Crossin, K. L., Bourdon, M. A., Pylela, R , and Sheppard, D. The integrin α9β1 mediates cell attachment to a non-RGD site in the third fibronectin type III repeat of tenascin. J. Biol. Chem., 269: 26691-26696, 1994.
4. Klein, C. E., Steinmayer, T , Kaufmann, D., Weber, L., and Bröcker, E-B. Identification of a melanoma progression antigen as integrin VLA-2 J. Invest. DermatoL, 96: 281-284, 1991.
5. Chen, F A., Repasky, E. A., and Bankert, R. B. Human lung tumor-associated antigen identified as an extracellular matrix adhesion molecule. J. Exp. Med., 173: 1111-1115, 1991.
6. Weinel, R. J., Rosendahl, A, Neumann, K., Chaloupka, B., Erb, D., Rothmund, M., and Santoso, S. Expression and function of VLA-α2, -α3, -α5 and α6-integrin receptors in pancreatic carcinoma. Int. J. Cancer, 52: 827-833, 1992.
7. Zutter, M. M., Mazoujian, G., and Santoro, S. A. Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am. J. Pathol., 137: 863-870, 1990.
8. Pignatelli, M., Smith, M. E. F., and Bodmer, W. F. Low expression of collagen receptors in moderate and poorly differentiated colorectal carcinomas Br. J. Cancer, 61. 636-638, 1990.
9. Kramer, R. H., and Marks, N. Identification of integrin collagen receptors on human melanoma cells. J. Biol. Chem., 264: 4684-4688, 1989.
10. Klein, C E., Dressel, D., Steinmayer, T., Mauch, C., Eckes, B., Krieg, T., Bankert, R. B., and Weber, L. Integrin α2β1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J. Cell Biol., 115: 1427-1436, 1991.
11. Schiro, J. A., Chan, B. M. C., Roswit, W. T., Kassner, P. D., Pentland, A. P., Hemler, M. E , Eisen, A Z., and Kupper, T S. Integrin α2β1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells. Cell, 67: 403-410, 1991.
12. Riikonen, T., Koivisto, L, Vihinen, P., and Heino, J. Transforming growth factor-β regulates collagen gel contraction by increasing α2β1 integrin expression in osteogenic cells. J. Biol Chem., 270: 376-382, 1995.
13. Yoshinaga, I. G., Vink, J., Dekker, S. K., Mihm, M. C., and Byers, H. R. Role of α3β1 and α2β1 integrins in melanoma cell migration. Melanoma Res., 3: 435-441, 1993.
14. Kern, A., Briesewitz, R., Bank, I., and Marcantonio, E. E. The role of the I domain in ligand binding of the human integrin α1β1. J. Biol. Chem., 269: 22811-22816, 1994.
15. Kamata, T., Puzon, W., and Takada, Y. Identification of putative ligand binding sites within I domain of integrin α2β1 (VLA-2. CD49b/CD29). J. Biol Chem., 269: 9659-9663, 1994.
16. Gullberg, D., Gehlsen, K. R., Turner, D. C , Åhlén, K., Zijenah, L. S., Barnes, M. J., and Rubin, K. Analysis of α1β1, α2β1 and α3β1 integrins in cell-collagen interactions: identification of conformation dependent α1β1 binding sites in collagen type I. EMBO J., 11: 3865-3873, 1992.
17. Riikonen, T., Westermarck, J., Koivisto, L., Broberg, A., Kähäri, V-M., and Heino, J. Integrin α2β1 is a positive regulator of collagenase (MMP-1) and collagen α1(I) gene expression. J. Biol. Chem., 270: 13548-13552, 1995
18. Languino, L. R., Gehlsen, K. R., Wayner, E., Carter, W. G., Engvall, E., and Ruoslahti, E. Endothelial cells use α2β1 integrin as a laminin receptor. J. Cell Biol., 109: 2455-2462, 1989
19. Kirchhofer, D., Languino, L. R., Ruoslahti, E., and Pierschbacher, M. D. α2β1 integrins from different cell types show different binding specificities. J. Biol. Chem., 265: 615-618, 1990.
20. Chan, B. M. C., and Hemler, M. E. Multiple functional forms of the integrin VLA-2 can be derived from a single α2 cDNA clone: interconversion of forms induced by an anti-β1 antibody. J. Cell Biol., 120; 537-543, 1993.
21. Spiramarao, P., Mendler, M., and Bourdon, M. A. Endothelial cell attachment and spreading on human tenascin is mediated by α2β1 and αVβ3 integrins. J. Cell Sci., 105: 1001-1012, 1993.
22. Rhim, J. S., Park, D. K., Amstein, P., Huebner, R. J., Weisburger, E. K., and Nelson-Rees, W. A. Transformation of human cells in culture by N-methyl-N′-nitro-N-nitrosoguanidine. Nature (Lond.), 256. 751-753, 1975.
23. Heino, J., Ignotz, R. A., Hemler, M. E., Crouse, C., and Massagué, J Regulation of cell adhesion receptors by transforming growth factor-β. J. Biol. Chem., 264: 380-388, 1989.
24. Santala, P., and Heino, J. Regulation of integrin-type cell adhesion receptors by cytokines. J. Biol. Chem., 266: 23505-23509, 1991.
25. 2+. J. Cell Biol., 117: 1109-1117, 1992.
26. Riikonen, T., Vihinen, P., Potila, M., Rettig, W , and Heino, J. Antibody against human α1β1 integrin inhibits HELA cell adhesion to laminin and to type I, IV, and V collagens. Biochem. Biophys. Res. Commun., 209. 205-212, 1995.
27. Santala, P., Larjava, H , Nissinen, L., Rukonen, T., Määttä, A., and Heino, J. Suppressed collagen gene expression and induction of α2β1 integrin-type collagen receptor in tumorigenic derivatives of human osteogenic sarcoma (HOS) cell line. J. Biol. Chem., 269: 1276-1283, 1994.
28. Takada, Y., and Hemler, M. E. The primary structure of the VLA-2/ collagen receptor α2 subunit (platelet GP la): homology to other integrins and the presence of a possible collagen-binding domain. J. Cell Biol , 109: 397-407, 1989.
29. Ohashi, P. S , Mak, T. W., Van den Elsen, P., Yanagi, Y., Yoshikai, Y., Calman, A., Terhorst, C., Stobo, J. D., and Weiss, A Reconstitution of an active surface T3/T-cell antigen receptor by DNA transfer. Nature (Lond.). 316: 606-609, 1985.
30. Plantefaber, L C., and Hynes, R. O. Changes in integrin receptors on oncogenically transformed cells. Cell, 56: 281-290, 1989.
31. Dedhar, S , and Saulnier, R. J. Alterations in integrin expression on chemically transformed human cells: specific enhancement of laminin and collagen receptor complexes. J. Cell Biol., 110: 481-489, 1990.
32. Robey, P. G., Fedarko, N. S., Hefferan, T E., Bianco, P., Vetter, U. K., Grzesik, W., Friedenstein, A. Van der Pluijm, G., Mintz, K. P., and Young, M. F. Structure and molecular regulation of bone matrix proteins J. Bone Miner. Res., 8: 483-487, 1993.
33. Clover, J., Dodds, R. A., and Gowen, M Integrin subunit expression by human osteoblasts and osteoclasts in situ and in culture. J. Cell Sci., 103. 267-271, 1992.
34. Michishita, M., Videm, V., and Arnaout, M. A. A novel divalent cation-binding site in the A domain of the β2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell, 72: 857-867, 1993.
35. Lee, J-O., Rieu, P., Arnaout, M. A., and Liddington, R. Crystal structure of the A domain from the a subunit of integrin CR3 (CD11b/CD18). Cell, 80: 631-638, 1995.
36. Giancotti, F. G , and Ruoslahti, E. Elevated levels of the α5β1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell, 60: 849-859, 1990.
37. Qian, F., Vaux, D. L., and Weissman, I. L. Expression of the integrin α4β1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell, 77: 335-347, 1994.
38. van Duinen, C. M., van den Broek, L. J. C. M., Vermeer, B J., Fleuren, G. J , and Bruijn, J. A. The distribution of cellular adhesion molecules in pigmented skin lesions. Cancer (Phila.), 73: 2131-2139, 1994.
39. Danen, E. H. J., Ten Berge, P. J. M , van Muijen, G. N. P., Van't Hof-Grootenboer, A. E , Bröcker, E. B., and Ruiter, D. J. Emergence of α5β1 fibronectin- and αvβ3 vitronectin-receptor expression in melanocytic tumour progression. Histopathol (Oxf.), 24: 249-256, 1994.
40. Chan, B. M. C., Matsuura, N., Takada, Y., Zetter, B. R., and Hemler, M. E. In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science (Washington DC). 251: 1600-1602, 1991.
41. Larjava, H., Lyons, J. G., Salo, T., Mäkelä, M., Koivisto, L., Birkedal-Hansen, H., Akiyama, S. K., Yamada, K. M., and Heino, J. Anti-integrin antibodies induce type IV collagenase expression in keratinocytes. J. Cell Physiol., 157: 190-200, 1993.
42. Seftor, R. E., Seftor, E. A., Gehlsen, K. R., Stetler-Stevenson, W. G., Brown, P. D., Ruoslahti, E., and Hendrix, M. J. Role of the αvβ3 integrin in human melanoma cell invasion Proc. Natl. Acad Sci. USA, 89: 1557-1561, 1992.
43. Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., Carlo, A., and Engler, J. A. Matrix metalloproteinases: a review. Crit Rev. Oral Biol Med., 4: 197-250, 1993.
44. Montgomery, A M P., Reisfeld, R. A., and Cheresh, D. A Integrin αvβ3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc. Natl. Acad. Sci. USA, 97: 8856-8860, 1994.
45. Werb, Z., Tremble, P. M., Behrendtsen, O., Crowley, E., and Damsky, C. H Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J. Cell Biol, 109: 877-889, 1989.
46. Pischel, K D., Hemler, M. E., Huang, C., Bluestein, H. G., and Woods, V. L Use of the monoclonal antibody 12F1 to characterize the differentiation antigen VLA-2. J. Immunol, 138: 226-233, 1987.